Antiinfectives targeting enzymes and the proton motive force

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2015-12-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.1521988112PMID 26644565PMCID PMC4697371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retraction Notice to: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule

  2017cited by this paper
• In vivo biosynthesis of terpene nucleosides provides unique chemical markers of Mycobacterium tuberculosis infection.

  2015cited by this paper
• A Molecular Dynamics Investigation of Mycobacterium tuberculosis Prenyl Synthases: Conformational Flexibility and Implications for Computer‐aided Drug Discovery

  2015cited by this paper
• Oxa, Thia, Heterocycle, and Carborane Analogues of SQ109: Bacterial and Protozoal Cell Growth Inhibitors.

  2015cited by this paper
• A new antibiotic kills pathogens without detectable resistance

  2015influential reference
• Lansoprazole is an antituberculous prodrug targeting cytochrome bc1

  2015cited by this paper
• Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives.

  2015cited by this paper
• Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase

  2015influential reference
• Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis

  2015cited by this paper
• SQ109, a New Drug Lead for Chagas Disease

  2015cited by this paper
• Bactericidal mode of action of bedaquiline.

  2015cited by this paper
• Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats

  2015cited by this paper
• Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c

  2014influential reference
• Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane.

  2014cited by this paper
• Niclosamide ethanolamine improves blood glycemic control and reduces hepatic steatosis in mice

  2014cited by this paper
• Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis

  2014influential reference
• Dronedarone, an Amiodarone Analog with Improved Anti-Leishmania mexicana Efficacy

  2014cited by this paper
• Estimating the economic costs of antimicrobial resistance

  2014influential reference
• Structural Insights into Ubiquinone Biosynthesis in Membranes

  2014cited by this paper
• Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925

  2014cited by this paper
• Resistance-resistant antibiotics.

  2014influential reference
• Intra- and Extracellular Activities of Trimethoprim-Sulfamethoxazole against Susceptible and Multidrug-Resistant Mycobacterium tuberculosis

  2014cited by this paper
• Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases

  2014influential reference
• RETRACTED: Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule.

  2014cited by this paper
• Structure and Inhibition of Tuberculosinol Synthase and Decaprenyl Diphosphate Synthase from Mycobacterium tuberculosis

  2014cited by this paper
• Pros and Cons of the Tuberculosis Drugome Approach – An Empirical Analysis

  2014cited by this paper
• New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

  2014influential reference
• Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells

  2013cited by this paper
• In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori

  2013cited by this paper
• Advances in the development of new tuberculosis drugs and treatment regimens

  2013cited by this paper
• Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?

  2013cited by this paper
• Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus.

  2013cited by this paper
• Measuring Interference of Drug-Like Molecules with the Respiratory Chain: Toward the Early Identification of Mitochondrial Uncouplers in Lead Finding

  2013cited by this paper
• Multitarget ligands in antibacterial research: progress and opportunities

  2013influential reference
• Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler.

  2013influential reference
• Electrogenic proton transport across lipid bilayer membranes mediated by cationic derivatives of rhodamine 19: comparison with anionic protonophores

  2013cited by this paper
• Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis

  2013cited by this paper
• Synthesis and evaluation of (2-(4-methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) isomers to reverse multidrug resistance in cancer.

  2012cited by this paper
• New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing

  2012cited by this paper
• Terpene biosynthesis: modularity rules.

  2012influential reference
• SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis

  2012influential reference
• Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosis

  2012cited by this paper
• Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals

  2012cited by this paper
• Liver-stage malaria parasites vulnerable to diverse chemical scaffolds

  2012cited by this paper
• Antibacterial drug leads targeting isoprenoid biosynthesis

  2012influential reference
• Clofazimine: current status and future prospects.

  2012cited by this paper
• Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

  2012influential reference
• The emerging role of amiodarone and dronedarone in Chagas disease

  2012cited by this paper
• Head-to-head prenyl tranferases: anti-infective drug targets.

  2012cited by this paper
• HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis.

  2012influential reference
• Adenylate Kinase Release as a High-Throughput-Screening-Compatible Reporter of Bacterial Lysis for Identification of Antibacterial Agents

  2012cited by this paper
• Pyrazinoic Acid Decreases the Proton Motive Force, Respiratory ATP Synthesis Activity, and Cellular ATP Levels

  2011cited by this paper
• Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes

  2011cited by this paper
• The structure-activity relationship of urea derivatives as anti-tuberculosis agents.

  2011cited by this paper
• Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis.

  2011cited by this paper
• Preparation of Highly Coupled Rat Heart Mitochondria

  2010cited by this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cited by this paper
• Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.

  2009cited by this paper
• NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance

  2009cited by this paper
• Protein structure prediction on the Web: a case study using the Phyre server

  2009cited by this paper
• The structural basis of chain length control in Rv1086.

  2008cited by this paper
• Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones.

  2008cited by this paper
• Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases

  2007cited by this paper
• Discovery and initial development of a novel class of antibacterials: inhibitors of Staphylococcus aureus transcription/translation.

  2006cited by this paper
• Platensimycin is a selective FabF inhibitor with potent antibiotic properties

  2006cited by this paper
• Identification et activité biologique d'une impureté du diuron technique

  2006cited by this paper
• Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.

  2006influential reference
• A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

  2005influential reference
• Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.

  2005cited by this paper
• Nitazoxanide: a new broad spectrum antiparasitic agent

  2004cited by this paper
• Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation.

  2004cited by this paper
• Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase

  2004influential reference
• Inhibitory Action of a Novel Proton Pump Inhibitor, Rabeprazole, and its Thioether Derivative Against the Growth and Motility of Clarithromycin‐Resistant Helicobacter pylori

  2001cited by this paper
• A Novel Action of the Proton Pump Inhibitor Rabeprazole and Its Thioether Derivative against the Motility of Helicobacter pylori

  2000cited by this paper
• Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp

  1997cited by this paper
• Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide

  1995cited by this paper
• Classical and Three-Dimensional QSAR in Agrochemistry

  1995cited by this paper
• The envelope of mycobacteria.

  1995cited by this paper
• The QSAR of Insecticidal Uncouplers

  1995cited by this paper
• The lipophilic weak base (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine (AU-1421) is a potent protonophore type cationic uncoupler of oxidative phosphorylation in mitochondria.

  1993cited by this paper
• Effects of N,N′-bis-(4-trifluoromethylphenyl)-urea on isolated plant mitochondria and thylakoid membranes

  1991cited by this paper
• Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.

  1986cited by this paper
• Cyanine and safranine dyes as membrane potential probes in cytochrome c oxidase reconstituted proteoliposomes.

  1985cited by this paper
• The identification and biological activity of an impurity of technical diuron.

  1979cited by this paper
• Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria.

  1974cited by this paper
• Chemiosmotic coupling in energy transduction: A logical development of biochemical knowledge

  1972influential reference
• Effects of cholesterol and cholesterol derivatives on hydrocarbon chain mobility in lipids.

  1971cited by this paper
• Double-Blind Controlled Clinical Trial of Clofazimine in Reactive Phases of Leprotamous Leprosy*

  1970cited by this paper
• Synthesis of potential antimalarials

  1970cited by this paper
• CHEMIOSMOTIC COUPLING IN OXIDATIVE AND PHOTOSYNTHETIC PHOSPHORYLATION

  1966influential reference
• alpha-(2-Piperidyl)-2-aryl-4-quinolinemethanols.

  1946cited by this paper
• The synthesis of potential antimalarials; 2-alkyl-alpha-(2-piperidyl)-4-quinolinemethanols.

  1946cited by this paper

• Protective mechanism of action of the antifungal drug naftifine against Mycobacterium abscessus infection

  2026cites this paper
• Antifungal Activity of Lipophilic Bisphosphonates.

  2026cites this paper
• Molecular modelling assisted identification of novel Benzoxazole derivatives as hit molecules targeting Mycobacterial Membrane Protein Large 3 (MmpL3).

  2026cites this paper
• Breakthroughs in the development of antibiotics, antifungals and antiparasitics targeting the pathogens’ respiratory chain

  2025cites this paper
• Common Biological Properties of Mycobacterium tuberculosis MmpL3 Inhibitors

  2025cites this paper
• A Transparent, Antimicrobial, Bio-Ionic Liquid Functionalized Hydrogel for Corneal Injury Repair.

  2025cites this paper
• Recent Developments in Structurally Diverse Anti-Tubercular Drug Molecules and Their Molecular Targets Against Mycobacterium tuberculosis

  2025cites this paper
• 2-Azido-4-nitrophenol is a light-sensitive antibacterial protonophore.

  2025cites this paper
• A potent phenylalkylamine disrupts mycobacterial membrane bioenergetics and augments bactericidal activity of bedaquiline

  2025cites this paper
• Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi.

  2025cites this paper
• Efficacy of novel regimens targeting oxidative phosphorylation in Mycobacterium tuberculosis

  2025cites this paper
• Activity of Carbazole, Aminoguanidine and Diamine Anti-infectives against Toxoplasma gondii

  2025cites this paper
• Anti-Parasitics with a Triple Threat: Targeting Parasite Enzymes, the Proton Motive Force, and Host Cell-Mediated Killing

  2025cites this paper
• Broad-Spectrum Activity and Mechanisms of Action of SQ109 on a Variety of Fungi

  2025cites this paper
• Inhibitors of NADH–O-methylquinone compound a class of antitubercular drugs

  2025cites this paper
• Effect of High‐Fat Diets on the Pharmacokinetics of Bedaquiline Fumarate Tablet: A Trial in Healthy Chinese Participants

  2025cites this paper
• A two-step screen identifies a small molecule that disrupts membrane voltage and is effective against growing and persister gram-negative bacteria

  2025cites this paper
• Activity of Antibacterial/Antifungal Compounds against the Protozoan Parasite, Toxoplasma gondii.

  2025cites this paper
• Discovery of antibacterial diketones against gram-positive bacteria.

  2024cites this paper
• Sodium, Potassium-Adenosine Triphosphatase as a Potential Target of the Anti-Tuberculosis Agents, Clofazimine and Bedaquiline

  2024cites this paper
• Spontaneous reversal of small molecule‐induced mitochondrial uncoupling: the case of anilinothiophenes

  2024cites this paper
• Proton motive force and antibiotic tolerance in bacteria

  2024cites this paper
• Exploration of vanoxerine analogues as antibacterial agents

  2024cites this paper
• Discovery of new antimicrobial thiophene derivatives with activity against drug-resistant Gram negative-bacteria

  2024cites this paper
• Water Disinfection: Unleashing the Power of Bicarbonate Ions in Chitosan–Silver Nanocomposite for Greener and More Efficient Silver Utilization

  2024cites this paper
• New functions of pirin proteins and a 2‐ketoglutarate: Ferredoxin oxidoreductase ortholog in Bacteroides fragilis metabolism and their impact on antimicrobial susceptibility to metronidazole and amixicile

  2024cites this paper
• Development of novel indole-quinoline hybrid molecules targeting bacterial proton motive force.

  2024cites this paper
• Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in Mycobacteria.

  2023cites this paper
• Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope.

  2023cites this paper
• In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis.

  2023cites this paper
• Mechanism of mycobacterial ATP synthase inhibition by squaramides and second generation diarylquinolines

  2023cites this paper
• Using a multi-omic approach to investigate the mechanism of 12-bis-THA activity against Burkholderia thailandensis

  2023cites this paper
• Multitargeting: An Alternative Approach to Tackling Multidrug Resistance Issues in Tuberculosis.

  2023cites this paper
• Study of SQ109 analogs binding to mycobacterium MmpL3 transporter using MD simulations and alchemical relative binding free energy calculations

  2023cites this paper
• Drug Repositioning as a Therapeutic Strategy against Streptococcus pneumoniae: Cell Membrane as Potential Target

  2023cites this paper
• Structural basis for inhibition of mycobacterial ATP synthase by squaramides and second generation diarylquinolines

  2023cites this paper
• Synthesis and Testing of Analogs of the Tuberculosis Drug Candidate SQ109 against Bacteria and Protozoa: Identification of Lead Compounds against Mycobacterium abscessus and Malaria Parasites.

  2023cites this paper
• Vanoxerine kills mycobacteria through membrane depolarization and efflux inhibition

  2023cites this paper
• Synthesis and Testing of Analogs of the Tuberculosis Drug SQ109 Against Bacteria and Protozoa: Identification of Lead Compounds Against Mycobacterium abscessus and Malaria

  2022cites this paper
• Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation

  2022cites this paper
• Fifty Years of Research on Protonophores: Mitochondrial Uncoupling As a Basis for Therapeutic Action

  2022cites this paper
• An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis

  2022cites this paper
• Alkyl esters of umbelliferone-4-acetic acid as protonophores in bilayer lipid membranes and ALDH2-dependent soft uncouplers in rat liver mitochondria.

  2022cites this paper
• Redox Cycling Dioxonaphthoimidazoliums Disrupt Iron Homeostasis in Mycobacterium bovis Bacillus Calmette-Guérin

  2022cites this paper
• Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis

  2022cites this paper
• Proton Motive Force Inhibitors Are Detrimental to Methicillin-Resistant Staphylococcus aureus Strains

  2022cites this paper
• Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors

  2022cites this paper
• Repurposing Vanoxerine as a new antimycobacterial drug and its impact on the mycobacterial membrane

  2022influential citation
• Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Mycobacterium abscessus

  2021cites this paper
• Impaired Succinate Oxidation Prevents Growth and Influences Drug Susceptibility in Mycobacterium tuberculosis

  2021cites this paper
• Clofazimine for babesiosis: preclinical data support a clinical trial.

  2021cites this paper
• Analysis of Six tonB Gene Homologs in Bacteroides fragilis Revealed That tonB3 is Essential for Survival in Experimental Intestinal Colonization and Intra-Abdominal Infection

  2021cites this paper
• Cytochrome bc1-aa3 oxidase supercomplex as emerging and potential drug target against tuberculosis.

  2021cites this paper
• Trialkyl(vinyl)phosphonium Chlorophenol Derivatives as Potent Mitochondrial Uncouplers and Antibacterial Agents

  2021cites this paper
• Active Efflux Leads to Heterogeneous Dissipation of Proton Motive Force by Protonophores in Bacteria

  2021cites this paper
• Structure, In Vivo Detection, and Antibacterial Activity of Metabolites of SQ109, an Anti-Infective Drug Candidate.

  2021cites this paper
• BAM15 treats mouse sepsis and sepsis-AKI, linking circulating mitochondrial DNA and tubule reactive oxygen species

  2021cites this paper
• Activating alternative transport modes in a multidrug resistance efflux pump to confer chemical susceptibility

  2021cites this paper
• Econazole as adjuvant to conventional antibiotics is able to eradicate starvation-induced tolerant bacteria by causing proton motive force dissipation.

  2021cites this paper
• Total synthesis and mechanism of action of the antibiotic armeniaspirol A

  2021cites this paper
• Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis

  2021cites this paper
• The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with Mycobacterium tuberculosis

  2021cites this paper
• Functionalized Dioxonaphthoimidazoliums: A Redox Cycling Chemotype with Potent Bactericidal Activities against Mycobacterium tuberculosis.

  2021cites this paper
• Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis

  2021cites this paper
• Study of the bioenergetics to identify the novel pathways as a drug target against Mycobacterium tuberculosis using Petri net

  2021cites this paper
• Clofazimine, a promising drug for the treatment of Babesia microti infection in severely immunocompromised hosts.

  2020cites this paper
• An overview of new antitubercular drugs, drug candidates, and their targets

  2020cites this paper
• Fluorescein Derivatives as Antibacterial Agents Acting via Membrane Depolarization

  2020cites this paper
• Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy

  2020cites this paper
• Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance

  2020influential citation
• Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis

  2020cites this paper
• Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections

  2020cites this paper
• Transcriptional Inhibition of the F1F0-Type ATP Synthase Has Bactericidal Consequences on the Viability of Mycobacteria

  2020cites this paper
• Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening

  2020cites this paper
• Bedaquiline inhibits the yeast and human mitochondrial ATP synthases

  2020cites this paper
• Bacterial Oxidases of the Cytochrome bd Family: Redox Enzymes of Unique Structure, Function, and Utility As Drug Targets

  2020cites this paper
• Mechanisms of action of ionic liquids on living cells: the state of the art

  2020cites this paper
• Protonophoric action of BAM15 on planar bilayers, liposomes, mitochondria, bacteria and neurons.

  2020cites this paper
• Discovery of Prenyltransferase Inhibitors with In Vitro and In Vivo Antibacterial Activity.

  2020cites this paper
• A small molecule that mitigates bacterial infection disrupts Gram-negative cell membranes and is inhibited by cholesterol and neutral lipids

  2020cites this paper
• The mitochondria-targeted derivative of the classical uncoupler of oxidative phosphorylation carbonyl cyanide m-chlorophenylhydrazone is an effective mitochondrial recoupler.

  2020cites this paper
• Title: Mechanistic understanding enables the rational design of salicylanilide

  2020cites this paper
• Identification of novel cyclin A2 binding site and nanomolar inhibitors of cyclin A2-CDK2 complex.

  2019cites this paper
• Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates

  2019cites this paper
• Direct Inhibition of MmpL3 by Novel Antitubercular Compounds

  2019cites this paper
• Mitophagy-Related Cell Death Mediated by Vacquinol-1 and TRPM7 Blockade in Glioblastoma IV

  2019cites this paper
• Mechanism of action of an old antibiotic revisited: Role of calcium ions in protonophoric activity of usnic acid.

  2019cites this paper
• 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain

  2019cites this paper
• Repurposing of Tamoxifen Against the Oral Bacteria.

  2019cites this paper
• Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications

  2019cites this paper
• Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery

  2019cites this paper
• A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3

  2019cites this paper
• Interaction of the anti-tuberculous drug bedaquiline with artificial membranes and rat erythrocytes.

  2019cites this paper
• Enhancing uptake of antibiotics into Gram-negative bacteria using nonribosome-targeting aminoglycoside-based adjuvants.

  2019cites this paper
• Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review

  2019cites this paper
• Mycobacterium tuberculosis releases an antacid that remodels phagosomes

  2019cites this paper
• Title A macrophage-based screen identifies antibacterial compounds selective for intracellular Salmonella Typhimurium Permalink

  2019cites this paper
• Natural flavones from Morus alba against MRSA via targeting the proton motive force and membrane permeability.

  2019cites this paper
• Mycobacterium tuberculosis Metabolism

  2019cites this paper
• 1H-Benzo[d]Imidazole Derivatives Affect MmpL3 in Mycobacterium tuberculosis

  2019cites this paper